LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway
Oxidative Medicine and Cellular Longevity · 2023
DOI: 10.1155/2023/8994901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2023. Verfasst von Bo Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Optometry, And Vision Science, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Signal Transduction, TOR Serine-Threonine Kinases, RNA, Long Noncoding, Uveal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Wenzhou Eye Hospital, Key R&D Program of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Uveal melanoma (UM) is an aggressive intraocular malignant tumour that is closely related to autophagic dysfunction. We aimed to identify autophagy-related long noncoding RNAs (lncRNAs) to elucidate the molecular mechanism of UM. Here, we show that LINC01278 is a new potential biomarker with clinical prognostic value in UM through bioinformatics analysis. Application of an autophagy inhibitor (3-MA) and an autophagy agonist (MG-132) indicated that LINC01278 can inhibit UM cell proliferation, migration, and invasion by inducing autophagy. A xenograft nude mouse model was used to examine the tumorigenesis of UM cells in vivo. Mechanistically, LINC01278 can inhibit the mTOR signalling pathway to activate autophagy, as shown by experiments with an mTOR agonist (MHY1485) and mTOR inhibitor (rapamycin) treatment. Our findings indicate that LINC01278 functions as a tumour suppressor by inhibiting the mTOR signalling pathway to induce autophagy. Targeting the LINC01278-mTOR axis might be a novel and promising therapeutic approach for UM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Optometry, And Vision Science, Wenzhou Medical University, Wenzhou, China.
- The Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, China.
- Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
ORCID-Profile: Chaoyang Zhang, Wencan Wu
Förderung
- Key R&D Program of Wenzhou Eye Hospital
- Key R&D Program of Zhejiang Province
- National Natural Science Foundation of China
- National Basic Research Program of China
Zitieren
APA
Liu, B., Yao, X., Zhang, C., Li, W., Wang, Y., Liao, Q., Li, Z., Huang, Q., Zhang, Y., & Wu, W. (2023). LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2023/8994901
Vancouver
Liu B, Yao X, Zhang C, Li W, Wang Y, Liao Q, et al. LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway. Oxidative Medicine and Cellular Longevity. 2023. doi:10.1155/2023/8994901
BibTeX
@article{Liu2023,
author = {Liu, Bo and Yao, Xueting and Zhang, Chaoyang and Li, Wenzhe and Wang, Yanan and Liao, Qianling and Li, Ziwei and Huang, Qinying and Zhang, Yanchen and Wu, Wencan},
title = {LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2023},
doi = {10.1155/2023/8994901}
}
EUVIMED